Delcath Systems, Inc.
|
|||
| Mailing Address: | 1633 Broadway, Suite 22C New York, New York 10019 |
Head Office Address: | 1633 Broadway, Suite 22C New York, New York 10019 |
| Contact Name: | David Hoffman | Principal Regulator: | Ontario |
| Business e-mail address: | dhoffman@delcath.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 212 489-2100 | Reporting Jurisdictions: | Other than Canada |
| Fax Number: | 212 489-2102 | Stock Exchange: | NASDAQ |
| Date of Formation: | Sep 28 2000 | Stock Symbol: | DCTH |
| Jurisdiction Where Formed: | Delaware | Auditor: | Marcum LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | N/A |
| CUSIP Number: | 24661P | Transfer Agent: | American Stock Transfer & Trust Co LLC |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $25,000,001 to $100,000,000 |
|
